Approval · Notice of Compliance 8481 · 2006
ENTROPHEN: Notice of Compliance 8481
Issued December 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8481
- Date
- December 20, 2006
- Company
- PendoPharm, Division of
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer name and product name
- Therapeutic class
- Analgesic, anti-inflammatory, antipyretic, platelet aggregation inhibitor
- Canadian reference product
- COATED ASPIRIN DAILY LOW DOSE 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTROPHEN | 02242281 | Marketed |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB